The startup develops immunomodulatory therapeutics that target autoimmunity and cancer by utilizing proprietary transcription data analysis to identify key immune system compartments. This approach enables healthcare professionals to tailor treatment plans for more effective patient outcomes.

BrightInsight provides a regulated digital health platform that enables biopharma and medtech companies to develop and manage Software as a Medical Device (SaMD) solutions, including companion apps and connected products. The platform enhances patient care by delivering measurable clinical and business outcomes, improving patient adoption and retention across various therapy areas.

Cleerly is a digital healthcare company that utilizes AI-based analysis of coronary computed tomography angiography (CCTA) imaging to quantify and characterize atherosclerosis, enabling precise identification of heart disease. This approach addresses the issue that over 70% of heart attack victims are misclassified as low risk by traditional methods, allowing for earlier and more personalized treatment plans.

Cogent Biosciences develops bezuclastinib, an oral, highly selective KIT inhibitor that targets activation‑loop mutations such as KIT D816V while sparing off‑target kinases. The drug is being evaluated in registration‑directed trials for systemic mastocytosis and imatinib‑resistant gastrointestinal stromal tumors, offering mutation‑specific therapy with reduced class‑related toxicities. Its design also supports combination with sunitinib to address resistance.

Edgewise Therapeutics is developing oral therapeutics targeting serious skeletal and cardiac muscle diseases, including a selective cardiac sarcomere modulator for hypertrophic cardiomyopathy and a fast skeletal myosin inhibitor for muscular dystrophies. The company addresses the unmet medical needs of patients suffering from life-limiting muscle disorders by advancing novel treatment options.

Electra Therapeutics is developing SIRP-directed antibodies that utilize a unique mechanism of action to target the underlying pathology of cancer and immunological diseases. The company focuses on addressing critical unmet therapeutic needs by advancing its pipeline of novel treatments.

ESCAPE Bio is a clinical-stage biopharmaceutical company developing small molecule drugs targeting neurodegenerative diseases such as Alzheimer's and Parkinson's. Their approach focuses on modulating specific biochemical pathways to slow disease progression and improve patient outcomes.

Develops a wireless, wearable Doppler ultrasound device that provides real-time hemodynamic assessments by measuring carotid arterial pulse metrics. This technology enables clinicians to optimize fluid resuscitation in critically ill patients, improving decision-making speed and accuracy in high-pressure environments like sepsis and septic shock management.

The startup offers a medicine management platform that analyzes drug discount programs through cloud-based data management and customizable insights. Its features include claims verification, dispute resolution, and discount monitoring, providing clients with a streamlined process for effective communication and payment verification.

Saniona specializes in the discovery and development of ion channel modulators, utilizing a proprietary drug discovery engine that has generated over 20,000 unique molecules. The company focuses on addressing neurological disorders, including epilepsy and hypothalamic obesity, by advancing multiple candidates through clinical trials.

Star Therapeutics develops best-in-class antibody therapies targeting serious diseases, with a focus on von Willebrand disease and other bleeding disorders. Their pipeline-in-a-product strategy utilizes novel biology to create effective treatments that meet the real-world needs of patients.

Sunbird Bio focused on advancing diagnostics for neurological disorders. The company developed technologies to improve the detection and understanding of these complex conditions. Their work aimed to support patient care through enhanced diagnostic tools.